diclofenac and hydrogen sulfide

diclofenac has been researched along with hydrogen sulfide in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (62.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caliendo, G; Cirino, G; Fiorucci, S; Santagada, V; Wallace, JL1
Bhatia, M; Li, L; Moore, PK; Sidhapuriwala, J; Sparatore, A1
Bhatia, M; Moore, PK; Sidhapuriwala, JN; Sparatore, A1
Berti, F; Del Soldato, P; Manfredi, B; Rossoni, G; Sparatore, A; Tazzari, V1
Baskar, R; Del Soldato, P; Moore, PK; Sparatore, A1
Del Soldato, P; Frantzias, J; Idris, AI; Logan, JG; Mollat, P; Ralston, SH; Sparatore, A1
Del Soldato, P; Giustarini, D; Rossi, R; Santus, G; Sparatore, A1
Olas, B1

Reviews

2 review(s) available for diclofenac and hydrogen sulfide

ArticleYear
Therapeutic potential of new hydrogen sulfide-releasing hybrids.
    Expert review of clinical pharmacology, 2011, Volume: 4, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Humans; Hydrogen Sulfide; Inflammation; Latanoprost; Levodopa; Prodrugs; Prostaglandins F, Synthetic

2011
Medical Functions of Hydrogen Sulfide.
    Advances in clinical chemistry, 2016, Volume: 74

    Topics: Angiogenesis Inducing Agents; Cardiovascular Agents; Cysteine; Diclofenac; Disulfides; Heart; Humans; Hydrogen Sulfide; Kidney; Levodopa; Prostaglandins F, Synthetic; Reperfusion Injury; Sulfides; Thioctic Acid; Thiones; Vasodilator Agents

2016

Other Studies

6 other study(ies) available for diclofenac and hydrogen sulfide

ArticleYear
Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
    Gastroenterology, 2007, Volume: 132, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diclofenac; Drug Design; Gastric Acid; Heterocyclic Compounds, 1-Ring; Humans; Hydrogen Sulfide; Male; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Stomach

2007
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat.
    European journal of pharmacology, 2007, Aug-13, Volume: 569, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hindlimb; Hydrogen Sulfide; Injections; Male; Neutrophils; Nitrates; Nitrites; Peroxidase; Rats; Rats, Wistar; Thiones

2007
Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury.
    Shock (Augusta, Ga.), 2008, Volume: 29, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ceruletide; Diclofenac; Disease Models, Animal; Hydrogen Sulfide; Lung; Lung Injury; Male; Mice; Pancreatitis, Acute Necrotizing; Thiones

2008
The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart.
    British journal of pharmacology, 2008, Volume: 153, Issue:1

    Topics: Animals; Creatine Kinase; Diclofenac; Epoprostenol; Glutathione; Glyburide; Heart; Hydrogen Sulfide; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Sulfides; Thiones; Ventricular Function, Left

2008
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation.
    European journal of pharmacology, 2008, Oct-10, Volume: 594, Issue:1-3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Diclofenac; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; Fluorescent Dyes; Hydrogen Sulfide; In Vitro Techniques; Indoles; Mitotic Index; Myocytes, Smooth Muscle; Rats; Thiones

2008
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
    British journal of pharmacology, 2012, Volume: 165, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Diclofenac; Female; Humans; Hydrogen Sulfide; I-kappa B Kinase; Mice; NF-kappa B; Osteoclasts; Osteolysis; Sulfones; Thiones

2012